Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Berry

Showing results (751-760 of 818) with videos related to

Pageof 82
Sort By:
American Journal of Human Genetics|March 21, 2000
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancerR Berry, D J Schaid, J R Smith, et al.
Urologic Oncology|December 5, 2009
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancerGuru Sonpavde, Ana M Aparicio, Feng Zhan, et al.
The New England Journal of Medicine|November 16, 2007
Cetuximab for the treatment of colorectal cancerDerek J Jonker, Chris J O'Callaghan, Christos S Karapetis, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Annals of Surgery|November 23, 2013
Pilot testing of a model for insurer-driven, large-scale multicenter simulation training for operating room teamsAlexander F Arriaga, Atul A Gawande, Daniel B Raemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancerHoward I Scher, Xiaoyu Jia, Kim Chi, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
BMJ Quality & Safety|January 14, 2011
Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety interventionAlex B Haynes, Thomas G Weiser, William R Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsJulie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
The New England Journal of Medicine|January 16, 2009
A surgical safety checklist to reduce morbidity and mortality in a global populationAlex B Haynes, Thomas G Weiser, William R Berry, et al.
Pageof 82

Showing results (751-760 of 818) with videos related to

Sort By:
Pageof 82
American Journal of Human Genetics|March 21, 2000
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancerR Berry, D J Schaid, J R Smith, et al.
Urologic Oncology|December 5, 2009
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancerGuru Sonpavde, Ana M Aparicio, Feng Zhan, et al.
The New England Journal of Medicine|November 16, 2007
Cetuximab for the treatment of colorectal cancerDerek J Jonker, Chris J O'Callaghan, Christos S Karapetis, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Annals of Surgery|November 23, 2013
Pilot testing of a model for insurer-driven, large-scale multicenter simulation training for operating room teamsAlexander F Arriaga, Atul A Gawande, Daniel B Raemer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancerHoward I Scher, Xiaoyu Jia, Kim Chi, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
BMJ Quality & Safety|January 14, 2011
Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety interventionAlex B Haynes, Thomas G Weiser, William R Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsJulie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
The New England Journal of Medicine|January 16, 2009
A surgical safety checklist to reduce morbidity and mortality in a global populationAlex B Haynes, Thomas G Weiser, William R Berry, et al.
Pageof 82